Condition (MeSH)
Intra-Abdominal Hypertension
ClinicalTrials.gov lists 67 trials for Intra-Abdominal Hypertension or a narrower condition beneath it. Potrero Medical has the most among industry and government lead sponsors, with 3.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase (log scale)
67 of the 67 trials are tagged with Intra-Abdominal Hypertension itself; the rest are tagged with a narrower condition beneath it.
When did Intra-Abdominal Hypertension trials start? (21)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 6
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 5 |
| 2025 | 3 |
| 2024 | 4 |
| 2023 | 3 |
| 2022 | 2 |
| 2021 | 4 |
| 2020 | 6 |
| 2019 | 6 |
| 2018 | 4 |
| 2017 | 5 |
Showing 10 of 21 earlier years.
No forecast is made for this condition: it averages 3.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Prediction, not a registry value: median of 33 months from start to primary completion across 5 trials still running at the 2026-10-09 snapshot; registered median of 14 months across 33 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Intra-Abdominal Hypertension trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 5 |
| Phase 4 | 6 |
| Not applicable | 21 |
| Observational | 34 |
How many Intra-Abdominal Hypertension trials are recruiting? (6)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 3 |
| Recruiting | 6 |
| Enrolling by invitation | 1 |
| Completed | 30 |
| Withdrawn | 3 |
Showing 5 of 6 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Intra-Abdominal Hypertension trials? (3)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Potrero Medical | 3 |
| Bursa Yuksek Ihtisas Training and Research Hospital | 2 |
| Dotspace Inc. | 1 |
Which drugs are being tested for Intra-Abdominal Hypertension? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| PROPOFOL | 1 |
Interventions as named in the registry (13)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Crystalloid Solutions | 1 |
| Furosemide-IR | 1 |
| tetrastarch (Voluven) | 1 |
| Furosemide 20 Milligrams | 1 |
| Neostigmine Methylsulfate 1 MG/ML | 1 |
Showing 5 of 13 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Intra-Abdominal Hypertension trials report? (4)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Single cardiovascular failure | 6 | 1 |
| Cardiovascular and renal failure | 2 | 1 |
| Cardiovascular and respiratory failure | 2 | 1 |
| Cardiovascular, respiratory and renal failure | 2 | 1 |
Which publications cover Intra-Abdominal Hypertension? (67)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Intra-abdominal hypertension and reverse Trendelenburg position increase frontal QRS-T angle in laparoscopic cholecystectomy: An observational study. | Medicine | 2025 | Yes |
| International cross-sectional survey on current and updated definitions of intra-abdominal hypertension and abdominal compartment syndrome. | World journal of emergency surgery : WJES | 2024 | Yes |
| Intra-abdominal hypertension in cardiac surgery patients: a multicenter observational sub-study of the Accuryn registry. | Journal of clinical monitoring and computing | 2023 | Yes |
| Continuous passive paracentesis versus large-volume paracentesis in the prevention and treatment of intra-abdominal hypertension in the critically ill cirrhotic patient with ascites (COPPTRIAHL): study protocol for a randomized controlled trial. | Trials | 2023 | Yes |
| The open abdomen in trauma, acute care, and vascular and endovascular surgery: comprehensive, expert, narrative review. | BJS open | 2023 | Yes |
Showing 5 of 67 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.